Effects of mosapride citrate on patients after vagal nerve, lower esophageal sphincter, and pyloric sphincter-preserving nearly total gastrectomy reconstructed by jejunal J pouch interposition, and postoperative quality of life

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 760-765

  Tomita, Ryouchi ^a,b   Igarashi, Seigo ^b   Fujisaki, Shigeru ^b   Kusafuka, Takeshi ^b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Early gastric cancer; Jejunal J pouch reconstruction; Mosapride citrate; Nearly total gastrectomy; QOL

Indexed keywords

MOSAPRIDE CITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON POUCH; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERVIEW; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOISOTOPE DIAGNOSIS; REFLUX ESOPHAGITIS; STOMACH CANCER; STOMACH EMPTYING; STOMACH PARESIS; SURGICAL PATIENT; TOTAL STOMACH RESECTION; WEIGHT GAIN;

ADULT; AGED; BENZAMIDES; COLONIC POUCHES; ESOPHAGEAL SPHINCTER, LOWER; FEMALE; GASTRECTOMY; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; HUMANS; JEJUNUM; MALE; MIDDLE AGED; MORPHOLINES; POSTOPERATIVE COMPLICATIONS; PYLORUS; QUALITY OF LIFE; VAGUS NERVE;

EID: 44349181421     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Fukuhara H, Imamaura H, Kodera K: The role of surgery in the current treatment of gastric cancer. Gastric Cancer 2002; 5:13-16.
2. Shimoyama S, Seto Y, Yasuda H, Mafune K, Kaminishi M: Concepts, rationale, and current outcomes of less invasive surgical strateges for early gastric cancer: data from a quarter-century of experience in single institution. World J Surg 2005; 29:58-65.
3. Woodward ER, Hocking MP: Postgastrectomy syndromes. Sur Clin North Am 1987; 67:509-520.
4. Wu CW, Hsieh MC, Lo SS, Lui WY, Peng FK: Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg 1997; 21:777-782.
5. Tomita R, Fujisaki S, Tanjoh K, Fukuzawa M: Relationship between gastroduodenal interdigestive migrating motor complex and quality of life in patients with subtotal gastrectomy for early gastric cancer. Int Surg 2000; 85:118-123.
6. Nishikawa K, Kawahara H, Yumiba T, Nishida T, Inoue Y, Ito T, Matsuda H: Functional characteristics of the pylorus in patients undergoing pylorus-preserving gastrectomy for early gastric cancer. Surgery 2002; 131:613-624.
7. Tomita R: A novel surgical procedure of vagal nerve, lower esophageal sphincter, and pyloric sphincter preserving nearly total gastrectomy reconstructed by single jejunal interposition, and postoperative quality of life. Hepatogastroenterology 2005; 52:1895-1901.
8. Maki T, Shiratori T, Hatafuku T, Sugawara K: Pylorus-preserving gastrectomy as an improved operation for gastric cancer. Surgery 1967; 61:838-845.
9. Tomita R, Fujisaki S, Tanjoh K: An operative technique on nearly total gastrectomy reconstructed by interposition of a jejunal J pouch with preservation of vagal nerve, lower esophageal sphincter and pyloric sphincter for early gastric cancer. World J Surg 2001; 25:1524-1531.
10. Nakane Y, Michiura T, Inoue K, Iiyama H, Okamura S, Yamamichi K, Hioki K: A randomized clinical trial of pouch reconstruction after total gastrectomy for cancer: which is better technique, Roux-en-Y or interposition? Hepatogastroenterology 2001; 48:903-907.
11. Ueno M, Iwahashi M, Nakamori M, Nakamura M, Ueda K, Tani M, Yamaue H: Complication of jejunal pouch interposition after proximal gastrectomy: case report. Hepatogastroenterology 2004; 57:916-918.
12. Tomita R, Tanjoh K, Fujisaki S: Novel operative technique for vagal nerve- and pyloric sphincter-preserving distal gastrectomy reconstructed by interposition of a 5 cm jejunal J pouch with a 3 cm jejunal conduit for early gastric cancer and postoperative quality of life 5 years after operation. World J Surg 2004; 28:766-7774.
13. Nomura E, Shinohara H, Mabuchi H, Sang-Woong L, Sonoda T, Tanigawa N: Postoperative evaluation of the jejunal pouch reconstruction following proximal and distal gastrectomy for gastric cancer. Hepatogastroenterology 2004; 59:1561-1566.
14. Tomita R, Tanjoh K, Fujisaki S: Relation between gastroduodenal Interdigestive migrating motor complex and postoperative gastrointestinal symptoms before and after cisapride therapy following distal gastrectomy for early gastric cancer. World J Surg 2000; 24:1250-1257.
15. Ramkumar D, Schulze KS: Gastrointestinal motility. Cur Opin Gastroenterol 2003; 19:540-545.
16. Cuomo R, Sarnelli G: Food intake and gastrointestinal motility. A complex interplay. Nutr Metab Cardiovasc Di.s 2004; 14:173-179.
17. Madan K, Ahuja V, Kashyap PC, Sharma MP: Comparision of efficay of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Dis Esophagus 2004; 17:274-278.
18. Cho YK, Choi MG, Han HW, Park JM, Oh JH, Jeong JJ, Cho YS, Lee IS, Kim SW, Choi KY, Chung IS: The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers. J Clin Gastroenterol 2006; 40:286-292.
19. Asakawa A, Ueno N, Katagi M, Ijuin Y, Moriya Y, Mizuno S, Inui T, Sakamaki R, Shinfuku N, Uemoto M: Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying. J Diabetes Complications 2006; 20:56-58.
20. Sakashita M, Yamaguchi T, Miyazaki H,Sekine Y, Nomiyama T, Tanaka S, Miwa T, Harasawa S: Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Arzneimittelforschung 1993; 43:867-872.
21. Endo J, Nomura N, Morishita S: Influence of mosapride citrate on gastric motility and autonomic nerves functions: evaluation by spectral analyses of heart rate and blood pressures, and by electrogastrography. J Gastroenterol 2002; 37:888-895.
22. Tomita R, Fujisaki S, Tanjoh K, Fukuzawa M: A novel operative technique on proximal gastrectomy reconstructed by interposition of a jejunal J pouch with preservation of vagal nerve and lower esophageal sphincter, Hepatogastroenterology 2001; 40:1186-1191.
23. Liedman B: Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients-is reconstruction with a reservoir worthwhile? Nutrition 1999; 15:677-682.
24. Tono C, Terashima M, Takagane A, Abe K: Ideal reconstruction after total gastrectomy by the interposition of a jejunal pouch considered by emptying time. World J Surg 2003; 27:1113-1118.
25. Behrns KE, Sarr MG: Diagnosis and management of gastric emptying disorders. Adv Surg 1994; 27:233-255.
26. Forstner-Barthell AW, Murr MM, Nitecki S, Camilleri M, Prather CM, Kelly KA, Sarr MG: Near-total gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 1999; 3:15-21.
27. Kanaizumi T, Nakano H, Matsui Y, Ishikawa H, Shimizu R, Park S, Kuriya N: Prokinetic effect of AS-4370 On gastric emptying in healthy adults. Eur J Clin Phamacol 1991; 41:335-337.
28. Itoh H, Nagano T, Takeyama M: Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin. Biol Pharm Bull 2001; 24:1072-1075.
29. Ruth M, Finizia C, Cange L, Lundell L: The effect of mosapride on esophageal motor function and acid reflux in patients with gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2003; 15:1115-1121.
30. Kinoshita Y, Hashimoto T, Kawamura A, Yuki M, Amano K, Sato H, Adachi K, Sato S, Oshima N, Takashima T, Kitajima M, Abe K, Suetsugu H: Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Phamacol Ther 2005; 21:37-41.
31. Asai H, Udaka F, Hirano M, Minami T, Oda M, Kubori T, Nishinaka K, Kameyama M, Ueno S: Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease. Parkinsonism Relat Disord 2005; 11:499-502.
32. Mine Y, Yoshikawa T, Oku S, Nagai K, Yoshida N, Hosoki K: Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther 1997; 283:1000-1008.
33. Tomita R, Munakat K, Kurosu Y, Tanjoh K: Gastric emptying time after distal gastrectomy with or without pylorus-preserving. J Smooth Muscle Res 1994; 20:229-231. (In Japanese)
34. Shiratori T, Hongo M, Ishii M: Interpretation of gastric emptying curve by RI method. J Smooth Muscle Res 1994; 30:433-437. (In Japanese)
35. Calvert EL, Whorwell PJ, Houghton LA: Inter-digestive and post-prandial antro-pyloro-duodenal motor activity in humans: effect of 5-hydroxytryptamine 1 receptor agonist. Aliment Pharmacol Ther 2004; 19:805-815.